Results 131 to 140 of about 25,232 (222)

5-ALA/Fe²⁺ attenuates testicular inflammatory injury and spermatogenic failure in non-obstructive azoospermia mice by suppressing the TP53-CASP3 apoptotic cascade. [PDF]

Front Cell Dev Biol
Zhu J, Zhai J, Xu Z, Wang Y, Xie J, Wang Y, Hou J, Xu K.   +7 more
europepmc   +1 more source

Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: Evolving Indications, Conditioning Strategies, and Outcomes. [PDF]

Hematol Rep
Alati C, Botti S, Cogliandro F, Pitea M, Pacilli M, Porto G, Policastro G, Sgarlata A, Mico MC, Loteta B, Giordano L, Santoro G, Germano J, Martino M.   +13 more
europepmc   +1 more source

In vivo T-cell depletion and pharmacokinetic-based busulfan conditioning regimen improve the outcomes in acute myeloid leukemia (AML) in complete remission undergoing to allogeneic stem cell transplantation. [PDF]

Cancer
Bono R, Rotolo C, Sapienza G, Spoto C, Costanza C, Indelicato S, Patti C, Mulè A, Calafiore V, Arrigo G, Santoro A, Di Noto L, Castagna L.   +12 more
europepmc   +1 more source

Long-term survival rates of thalassemia patients following hematopoietic stem cell transplantation: A systematic review and meta-analysis. [PDF]

Hematol Transfus Cell Ther
Adisuhanto M, Prasetya A, Cahyadi A, Oehadian A.   +3 more
europepmc   +1 more source

Clinical Impact of Maximum Plasma Concentration of Busulfan in Pediatric Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation. [PDF]

Clin Pharmacol Ther
Bae S, Choi JY, Hong KT, Kim BK, Park HJ, Yu KS, Rhee SJ, Kang HJ.   +7 more
europepmc   +1 more source

Refining busulfan exposure enhances pediatric ALL HSCT outcomes: insights from the International FORUM study. [PDF]

Blood Adv
Ben Hassine K, Gloor Y, Dupanloup I, Uppugunduri CRS, Mlakar V, Gonzales F, Güngör T, Ifversen M, Shaw PJ, Buechner J, Truong TH, Bittencourt H, Teague L, Toporski J, Sedlacek P, Poetschger U, Krajinovic M, Kałwak K, Balduzzi A, Algeri M, Bader P, Peters C, Dalle JH, Ansari M.   +23 more
europepmc   +1 more source

From Therapeutic Drug Monitoring to Model-Informed Precision Dosing: A Review of Busulfan Dosing Optimization in Pediatric Hematopoietic Stem Cell Transplantation. [PDF]

Pharmaceutics
Zhang XY, Li Y, Xu J, Fang YJ, Ding XS, Chen F.   +5 more
europepmc   +1 more source

Post-Transplant Cyclophosphamide-Based Related Haploidentical Transplantation for Adult Diamond-Blackfan Anemia: Long-Term Survival and Review. [PDF]

J Hematol
Sakakibara T, Kobayashi S, Ito T, Tachibana M, Ito E.   +4 more
europepmc   +1 more source

Cost analysis of allogeneic hematopoietic stem cell transplantation before and after the implementation of therapeutic drug monitoring. [PDF]

Hematol Transfus Cell Ther
Zuckermann J, da Silva Etges APB, Mateus de Castro B, Garcia Ruschel R, Rodrigues de Lara L, Bastos Beltrami L, Teresinha Chagas E, Daudt LE, Aparecida Paz A, Moreira LB.   +9 more
europepmc   +1 more source

Yes, we can omit TBI for ALL! [PDF]

Blood Adv
Boelens JJ, Dvorak CC.
europepmc   +1 more source